{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:29:05Z","timestamp":1790749745078,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.vaccine.2010.10.028","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T08:35:33Z","timestamp":1288082133000},"page":"26-33","source":"Crossref","is-referenced-by-count":2,"title":["Determination of antigenic properties of vaccine derived poliovirus strains"],"prefix":"10.1016","volume":"29","author":[{"given":"Vaia","family":"Pliaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis","family":"Achilleos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaharoula","family":"Kyriakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Tsakogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Georgia Anna","family":"Ruether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantina","family":"Gartzonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatina","family":"Levidiotou-Stefanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayotis","family":"Markoulatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.10.028_bib0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.ge.27.120193.002033","article-title":"Genetics of poliovirus","volume":"27","author":"Wimmer","year":"1993","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0264-410X(83)90007-5","article-title":"Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2, and VP3","volume":"1","author":"Van der Marel","year":"1983","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0015","first-page":"124","article-title":"Antigenic structure of picornaviruses","volume":"161","author":"Minor","year":"1990","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived poliovirus and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0025","first-page":"1","article-title":"Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","author":"CDC","year":"1997","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0030","first-page":"133","article-title":"Expanding contributions of the global laboratory network for poliomyelitis eradication","volume":"77","author":"World Health Organization","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0035","first-page":"341","article-title":"Laboratory surveillance for wild and vaccine-derived polioviruses, January 2002\u2013June 2003","volume":"78","author":"World Health Organization","year":"2003","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biologicals.2006.02.007","article-title":"Vaccine-derived polioviruses","volume":"34","author":"Agol","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/viro.1993.1468","article-title":"Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis","volume":"196","author":"Furione","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0050","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1128\/JVI.71.10.7758-7768.1997","article-title":"Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis","volume":"71","author":"Georgescu","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0055","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/JVI.79.2.1062-1070.2005","article-title":"Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine","volume":"79","author":"Cherkasova","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0060","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/JVI.80.6.2641-2653.2006","article-title":"Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties","volume":"80","author":"Yakovenko","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0065","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1016\/j.vaccine.2007.04.007","article-title":"Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people","volume":"25","author":"Boot","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0070","doi-asserted-by":"crossref","first-page":"10960","DOI":"10.1128\/JVI.76.21.10960-10971.2002","article-title":"Recombination of poliovirus RNA proceeds in mixed replication complexes originating from distinct replication start sites","volume":"76","author":"Egger","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0075","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s100960100610","article-title":"Sabin type 2 polioviruses with intertypic vaccine\/vaccine recombinant genomes","volume":"20","author":"Georgopoulou","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mcp.2003.09.009","article-title":"Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees","volume":"18","author":"Karakasiliotis","year":"2004","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0090","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1099\/vir.0.18708-0","article-title":"Characterization of a recombinant type 3\/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1","volume":"84","author":"Blomqvist","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0095","doi-asserted-by":"crossref","first-page":"10921","DOI":"10.1128\/JVI.76.21.10921-10928.2002","article-title":"Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis","volume":"76","author":"Mart\u00edn","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1574-695X.2008.00381.x","article-title":"Complete genomic characterization of an intertypic Sabin3\/Sabin2 capsid recombinant","volume":"52","author":"Dedepsidis","year":"2008","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0105","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1099\/0022-1317-76-9-2343","article-title":"Tripartite genome organization of a natural type 2 vaccine\/nonvaccine recombinant poliovirus","volume":"76","author":"Georgescu","year":"1995","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0110","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1099\/0022-1317-83-12-3103","article-title":"Genetic recombination in wild-type poliovirus","volume":"83","author":"Dahourou","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0115","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1128\/JVI.77.16.8973-8984.2003","article-title":"Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region","volume":"77","author":"Brown","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0120","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1128\/JVI.78.24.13512-13521.2004","article-title":"Circulation of type 1 vaccinederived poliovirus in the Philippines in 2001","volume":"78","author":"Shimizu","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0125","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3201\/eid0907.020692","article-title":"Recombinant vaccine-derived poliovirus in Madagascar","volume":"9","author":"Rousset","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2010.10.028_bib0130","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.ppat.1000412","article-title":"Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses","volume":"5","author":"Jegouic","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0135","first-page":"55","article-title":"Preventive medicine and the Ministry of Social Services","volume":"14","author":"Stefanou","year":"1980","journal-title":"Hell Arm Forces Med Rev"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF03334982","article-title":"Poliomyelitis cases in Northern Greece 1976\u20131990","volume":"8","author":"Frantzidou-Adamopoulou","year":"1992","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.028_bib0145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11262-010-0448-9","article-title":"Growth kinetic analysis of bi-recombinant poliovirus vaccine strains","volume":"40","author":"Pliaka","year":"2010","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0150","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1099\/vir.0.80823-0","article-title":"Evolution of a rare vaccine-derived multirecombinant poliovirus","volume":"86","author":"Karakasiliotis","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11262-005-6877-1","article-title":"Genomic analysis of recombinant sabin clinical isolates","volume":"32","author":"Paximadi","year":"2006","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0160","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11262-007-0146-4","article-title":"Vaccine derived bi- and multi-recombinant Sabin strains","volume":"35","author":"Paximadi","year":"2007","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0165","series-title":"Manual for the virological investigation of poliomyelitis","author":"WHO","year":"1997"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0170","doi-asserted-by":"crossref","DOI":"10.1111\/j.1469-0691.2010.03188.x","article-title":"A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece","author":"Pliaka","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2010.10.028_bib0175","first-page":"157","article-title":"Status of immunity against poliomyelitis: a study among European and extra-European young immigrants living in Parma","volume":"76","author":"Affanni","year":"2005","journal-title":"Acta Biomed"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.028_bib0180","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/infdis\/162.4.971","article-title":"Response to trivalent oral poliovirus vaccine with and without immune serum globulin in young adults in Israel in 1988","volume":"162","author":"Green","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0166-0934(94)00173-E","article-title":"New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay","volume":"53","author":"Casas","year":"1995","journal-title":"J Virol Meth"},{"issue":"3","key":"10.1016\/j.vaccine.2010.10.028_bib0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mcp.2009.11.003","article-title":"A new RT-PCR assay for the identification of the predominant recombination types in 2C and 3D genomic regions of vaccine-derived poliovirus strains","volume":"24","author":"Pliaka","year":"2010","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0195","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1128\/AEM.00535-07","article-title":"Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece","volume":"73","author":"Dedepsidis","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0200","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1099\/0022-1317-67-7-1283","article-title":"Antigenic structures of polioviruses of serotypes 1, 2 and 3","volume":"67","author":"Minor","year":"1986","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0205","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1006\/viro.1995.0067","article-title":"Canyon rim residues, including antigenic determinants, modulate serotype specific binding of polioviruses to mutants of the poliovirus receptor","volume":"214","author":"Harber","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1073\/pnas.97.1.79","article-title":"Interaction of the poliovirus receptor with poliovirus","volume":"97","author":"He","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0215","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1128\/JVI.76.13.6791-6799.2002","article-title":"Long-term circulation of vaccine-derived poliovirus that causes paralytic disease","volume":"76","author":"Cherkasova","year":"2002","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2010.10.028_bib0220","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/JVI.69.8.4972-4978.1995","article-title":"Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine","volume":"69","author":"Bouchard","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0225","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0042-6822(89)90183-9","article-title":"Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees","volume":"172","author":"Macadam","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/viro.1993.1003","article-title":"Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates","volume":"192","author":"Macadam","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0235","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1099\/0022-1317-70-5-1117","article-title":"The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3","volume":"70","author":"Minor","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0240","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/JVI.65.3.1377-1382.1991","article-title":"Identification of two determinants that attenuate vaccine-related type 2 poliovirus","volume":"65","author":"Ren","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0245","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/JVI.63.3.1338-1344.1989","article-title":"Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine","volume":"63","author":"Westrop","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0250","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1016\/j.vaccine.2008.07.101","article-title":"Epidemiology of poliomyelitis-Options and update","volume":"26","author":"Dutta","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0255","series-title":"Polio laboratory manual (WHO\/IVB\/04.10)","author":"World Health Organization","year":"2004"},{"issue":"7","key":"10.1016\/j.vaccine.2010.10.028_bib0260","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/JVI.02122-08","article-title":"Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance","volume":"83","author":"Yakovenko","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0265","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1086\/516312","article-title":"Outbreak of paralytic poliomyelitis in Albania 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination","volume":"26","author":"Prevots","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0270","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/JCM.36.7.1912-1918.1998","article-title":"Antigenic and molecular characterization of wild type 1 poliovirus causing outbreaks of poliomyelitis in Albania and neighboring countries in 1996","volume":"36","author":"Fiore","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0275","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0264-410X(93)90342-U","article-title":"Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization","volume":"11","author":"Green","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0280","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0264-410X(98)00071-1","article-title":"Immune response to an intercalated enhanced inactivated polio vaccine\/oral polio vaccine programme in Israel: impact on the control of poliomyelitis","volume":"16","author":"Swartz","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0285","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1469-0691.2004.00998.x","article-title":"A seroprevalence study of poliovirus antibody in the population of northern Greece","volume":"11","author":"Frantzidou","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0290","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jcv.2006.03.003","article-title":"Polio\u2014new challenges in 2006","volume":"36","author":"Katz Samuel","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0295","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/bmj.293.6555.1153","article-title":"Prevalence of antibody to polioviruses in England and Wales 1984\u20136","volume":"293","author":"White","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0300","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0264-410X(96)00208-3","article-title":"Immunity status against poliomyelitis in persons 13\u201314 years old living in Rome","volume":"15","author":"Mastroeni","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/JVI.57.1.81-90.1986","article-title":"Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site","volume":"57","author":"Blondel","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0310","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1128\/JVI.78.9.4876-4883.2004","article-title":"Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia","volume":"78","author":"Blomqvist","year":"2004","journal-title":"J Virol"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2010.10.028_bib0315","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1099\/0022-1317-71-6-1271","article-title":"Differences in conformation of type 3 poliovirus antigenic sites on non-infectious empty particles and infectious virus","volume":"71","author":"Ferguson","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0320","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0042-6822(91)90434-D","article-title":"The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay","volume":"184","author":"Balanant","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0325","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1099\/0022-1317-80-4-907","article-title":"A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1","volume":"80","author":"Mulders","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.10.028_bib0330","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11262-005-0055-3","article-title":"Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine","volume":"33","author":"Dedepsidis","year":"2006","journal-title":"Virus Genes"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10014970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10014970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T20:24:36Z","timestamp":1711916676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10014970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0264410X10014970"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.10.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}